Objective: A summary of main aspects from a Health Technology
Assessment report on Traditional Chinese Medicine (TCM) in
Switzerland concerning effectiveness and safety is given. Materials
and Methods: Literature search was performed through 13
databases, by scanning reference lists of articles and by contacting
experts. Assessed were quality of documentation, internal
and external validity. Results: Effectiveness: 43 articles concerning
‘gastrointestinal tract and liver’ were assessed. The studies
covering 7,436 patients were undertaken in China (35),
Japan (3), USA (2) and Australia (3); 33/43 being controlled studies.
34/40 show significantly better results in the TCM-treated
group. A comparison of studies on results of treatment based
on a diagnosis according to TCM criteria and studies on results
of treatment according to Western diagnosis shows that treatment
based on TCM diagnosis improves the result. The comparison
of treatment by individual medication and standard medication
showed a trend in favor of individual medication. Safety:
TCM training and practice for physicians in Switzerland are officially
regulated. Side effects occur, but no severe effects have
been registered up to now in Switzerland. TCM medicinals are
imported; admission regulations are being installed. Problems
due to production abroad, Internet trade, self-medication or admixtures
are possible. Conclusion: The evaluation of the literature
search provides evidence for a basic clinical effectiveness
of TCM therapy. Severe side effects were not observed in Switzerland.
Regulations for trading and use of medicinals prevent
treatment risks. Further clinical studies in a Western context are
required.